Investors
Invest deal by deal. Build with us toward more.
Celer Capital operates as an independent sponsor. We source, structure, and operate acquisitions, and partner with investors on a transaction-by-transaction basis — with a long-term view toward a dedicated fund.
The Business Model
Buy and build.
The firm acquires strong, founder-owned businesses in fragmented care markets, strengthens them with systems, talent, and shared operating resources, and compounds them into durable platforms — acquisition by acquisition. Fragmented supply, demographic demand, and proven institutional exits are the three pillars; the market research documents each one.
The Independent Sponsor Model
Why sophisticated capital likes this structure.
01
Deal-by-deal alignment
As an independent sponsor, we present each acquisition individually. You see the specific business, the specific thesis, and the specific terms — and choose deal by deal.
02
Skin in the game
We invest alongside our partners and earn primarily through performance. Our economics depend on outcomes, not on gathering assets.
03
Operator discipline
Capital is deployed into businesses we actively help operate and build — not passively held positions.
04
A path toward a fund
Our deal-by-deal record is the foundation for a potential dedicated fund. Early partners build the relationship — and the track record — with us.
Track Record
Experience that compounds.
Celer Capital is supported by an investment team with substantial experience across acquisitions, operations, healthcare, and business building.
100+
Transactions completed across our investment team.
250+
Years of cumulative experience across leadership.
$10B+
Public and private transaction value combined.
12–40
Healthcare acquisitions targeted through 2025–2028.
Forward-looking acquisition target
Track-record figures represent aggregate experience of members of the investment and leadership team and may include activity completed prior to joining Celer Capital. Transaction-value figures include public and private transactions combined. Healthcare acquisition figures represent a target for 2025–2028, not completed acquisitions. Details are subject to verification and may be updated.
Who we partner with.
Family offices
High-net-worth and accredited private investors
Institutional investors exploring the lower middle market
Co-investors and other sponsors
Lenders and structured-capital providers
Current focus
Our active pipeline is concentrated in healthcare services — U.S. home health, assisted living, and home care — alongside selective opportunities in business services and other sectors. Opportunity-specific materials are shared under confidentiality with qualified investors.
See the Market ResearchPlatform Partners
Want a bigger seat at the table?
Beyond deal-by-deal co-investment, we welcome conversations with family offices, institutions, and strategic partners interested in a deeper relationship with the Celer Capital platform itself — anchor capital, programmatic co-investment, or a strategic combination.
Anchor capital
Back the platform's acquisition pipeline with committed or programmatic capital and preferred access to deal flow.
Programmatic co-investment
A standing relationship: see every qualifying deal first, on pre-agreed terms, without re-negotiating each time.
Strategic combination
Acquirers and platforms interested in Celer Capital itself — our pipeline, our team, our model — are welcome to start a confidential conversation.
Our acquisition platform is built for velocity — we target multiple completed acquisitions per month at scale, supported by our 12–40 healthcare acquisition target for 2025–2028. Pace figures are forward-looking targets, not completed results.
Start the conversation.
Tell us who you are and what you are looking for. We respond personally and treat every conversation as confidential.
This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any investment opportunity is offered only to qualified investors through definitive transaction documents, on a deal-by-deal basis. References to a potential future fund are aspirational and do not constitute an offering. Investing involves risk, including possible loss of principal.